A mandate is “a business, or element of a business, in which the subsidiary participates and for which it has responsibilities beyond its national market” (Birkinshaw, 1996, p. 467). In the past MNCs set up subsidiaries as miniature replicas of the parent firm but with a changing global market the role of the subsidiary has developed into holding specific mandates. Much has been written about how subsidiaries gain mandates, but in this paper we focus on what causes a subsidiary to lose its mandate. By using AstraZeneca’s R&D unit in Södertälje as a case we examine the loss of mandates and to what extent technological capabilities are connected to the loss of mandates. The paper shows that explaining the loss of mandates is complex and requires consideration of several perspectives. We here provide a starting point for other researchers to continue upon.
| Identifer | oai:union.ndltd.org:UPSALLA1/oai:DiVA.org:uu-226807 |
| Date | January 2014 |
| Creators | Thorn, Kristina, Ceciliano, Rodrigo |
| Publisher | Uppsala universitet, Företagsekonomiska institutionen, Uppsala universitet, Företagsekonomiska institutionen |
| Source Sets | DiVA Archive at Upsalla University |
| Language | English |
| Detected Language | English |
| Type | Student thesis, info:eu-repo/semantics/bachelorThesis, text |
| Format | application/pdf |
| Rights | info:eu-repo/semantics/openAccess |
Page generated in 0.0017 seconds